Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Alliance Resource Partners, L.P. Announces Fourth Quarter 2023 Earnings Conference Call: https://mms.businesswire.com/media/20210412005210/en/1052735/5/LOGO_ARLP.jpg
Alliance Resource Partners, L.P. Announces Fourth Quarter 2023 Earnings Conference Call


Alliance Resource Partners, L.P. (NASDAQ: ARLP) will report its fourth quarter 2023 financial results before the market opens on Monday, January 29, 2024. Alliance management will discuss these

Manhattan Debuts the First and Only Fulfillment Experience Insights Dashboard for Retail: https://mms.businesswire.com/media/20230808247863/en/1860989/5/Manh_Logo_NoTag_Blue_CMYK.jpg
Manhattan Debuts the First and Only Fulfillment Experience Insights Dashboard for Retail


Manhattan Associates (NASDAQ: MANH), the global leader in supply chain commerce, today launched the Fulfillment Experience Insights dashboard to give retailers a realtime assessment of how their

Shopify and Manhattan to Build Unified Commerce Solution: https://mms.businesswire.com/media/20230808247863/en/1860989/5/Manh_Logo_NoTag_Blue_CMYK.jpg
Shopify and Manhattan to Build Unified Commerce Solution


Manhattan Associates (NASDAQ: MANH), the global leader in supply chain commerce, and leading global commerce company, Shopify (NYSE, TSX: SHOP), announced a new alliance today to help retailers

JetBlue Announces Record and Payment Dates for January 2024 Additional Prepayment to Spirit Stockholders
JetBlue Announces Record and Payment Dates for January 2024 Additional Prepayment to Spirit Stockholders


As previously announced, in connection with the Agreement and Plan of Merger, dated as of July 28, 2022 (the “Merger Agreement”), by and among JetBlue Airways Corporation (“JetBlue”) (NASDAQ

Royal Gold Presenting at the 27th Annual CIBC Western Institutional Investor Conference: https://mms.businesswire.com/media/20191106005902/en/190143/5/Royal_Gold_Logo_-_no_shadow_-_Mar_07.jpg
Royal Gold Presenting at the 27th Annual CIBC Western Institutional Investor Conference


Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company,” “we” or “our”) announced today that management will present in the 27th Annual CIBC Western

Travis Perkins: Director/PDMR Shareholding
Travis Perkins: Director/PDMR Shareholding
Travis Perkins: Director/PDMR Shareholding
Independent Bank Group, Inc. Announces Date for Q4 2023 Earnings Call: https://mms.businesswire.com/media/20210405005114/en/869069/5/4969461_IFBankGroup_Logo_S_4C.jpg
Independent Bank Group, Inc. Announces Date for Q4 2023 Earnings Call


Independent Bank Group, Inc. (NASDAQ: IBTX), the holding company for Independent Financial, will hold a conference call to discuss fourth quarter and full year 2023 results on Tuesday, January 23

Monro, Inc. to Report Third Quarter Fiscal 2024 Earnings on January 24, 2024: https://mms.businesswire.com/media/20220505005166/en/1443918/5/MNRO_Logo.jpg
Monro, Inc. to Report Third Quarter Fiscal 2024 Earnings on January 24, 2024


Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, will release its fiscal 2024 third quarter earnings on January 24, 2024. The Company will host a

onsemi to Announce Fourth Quarter and 2023 Annual Financial Results: https://mms.businesswire.com/media/20210805005288/en/1169226/5/onsemi_logo_no_mark_1920x1080.jpg
onsemi to Announce Fourth Quarter and 2023 Annual Financial Results


onsemi (Nasdaq: ON) plans to announce its financial results for the fourth quarter, which ended December 31, 2023, before the market opens on Monday, February 5, 2024.



The company will host a

Acadia Healthcare and Ascension Seton Form Joint Venture to Expand Behavioral Health Services in Austin: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare and Ascension Seton Form Joint Venture to Expand Behavioral Health Services in Austin


Ascension Seton and Acadia Healthcare announced today that the two organizations have formed a joint venture to expand access to behavioral healthcare in Austin, Texas, and surrounding communities

Acadia Healthcare Enters Into a Joint Venture Partnership With Ascension Seton to Expand Behavioral Health Services in Austin, Texas: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Enters Into a Joint Venture Partnership With Ascension Seton to Expand Behavioral Health Services in Austin, Texas


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has formed a joint venture partnership with Ascension Seton, one of the leading, integrated healthcare systems in Austin

Royal Gold Provides Update on its Q4 2023 Stream Segment Sales and Details for Release of Q4 2023 Results: https://mms.businesswire.com/media/20191106005902/en/190143/5/Royal_Gold_Logo_-_no_shadow_-_Mar_07.jpg
Royal Gold Provides Update on its Q4 2023 Stream Segment Sales and Details for Release of Q4 2023 Results


Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company,” “we” or “our”) announced today that its wholly owned subsidiary, RGLD Gold AG, sold approximately

ICON Issues Financial Guidance for Full Year 2024: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON Issues Financial Guidance for Full Year 2024


ICON plc, (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today announced its financial guidance for the year ending December 31, 2024. For the

Novocure Announces Last Patient Enrolled in Phase 3 TRIDENT Trial in Newly Diagnosed Glioblastoma: https://mms.businesswire.com/media/20191120005453/en/721126/5/novocure_main%405x.jpg
Novocure Announces Last Patient Enrolled in Phase 3 TRIDENT Trial in Newly Diagnosed Glioblastoma


Novocure (NASDAQ: NVCR) today announced that the final patient has been enrolled in the global phase 3 TRIDENT clinical trial evaluating the safety and efficacy of initiating Optune Gio® (formerly

Helmerich & Payne, Inc. Announces Fiscal First Quarter 2024 Conference Call and Webcast: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24508/Helmerich___Payne_logo.png
Helmerich & Payne, Inc. Announces Fiscal First Quarter 2024 Conference Call and Webcast


In conjunction with Helmerich & Payne, Inc.’s (NYSE: HP) first quarter 2024 earnings release, you are invited to listen to its conference call on Tuesday, January 30, 2024, at 11:00 a.m. (ET) with

Manhattan Associates Announces Date for Reporting Fourth Quarter 2023 Financial Results: https://mms.businesswire.com/media/20230808247863/en/1860989/5/Manh_Logo_NoTag_Blue_CMYK.jpg
Manhattan Associates Announces Date for Reporting Fourth Quarter 2023 Financial Results


Manhattan Associates Inc. (NASDAQ: MANH) today announced it will release its fourth quarter 2023 financial results on Tuesday, January 30, 2024, after the stock market closes. The press release

LivaNova to Wind Down Advanced Circulatory Support Business Unit: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova to Wind Down Advanced Circulatory Support Business Unit


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that it will commence immediately with an orderly wind down of the Advanced Circulatory Support (ACS)

Novocure Announces Preliminary Full Year and Fourth Quarter 2023 Net Revenues and Provides Company Update: https://mms.businesswire.com/media/20191120005453/en/721126/5/novocure_main%405x.jpg
Novocure Announces Preliminary Full Year and Fourth Quarter 2023 Net Revenues and Provides Company Update


Novocure (NASDAQ: NVCR) today reported preliminary unaudited financial results and operational updates for the quarter and full year ended December 31, 2023. Novocure is a global oncology company

Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON


ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today launched its “Optimising biotech funding” whitepaper. This provides an overview of the

Aperam announces its financial calendar for 2024
Aperam announces its financial calendar for 2024
Aperam announces its financial calendar for 2024
Aperam announces its financial calendar for 2024
Aperam announces its financial calendar for 2024
Aperam announces its financial calendar for 2024
Notice of AGM
Notice of AGM
Notice of AGM
Novocure Appoints Dr. Nicolas Leupin as Chief Medical Officer: https://mms.businesswire.com/media/20191120005453/en/721126/5/novocure_main%405x.jpg
Novocure Appoints Dr. Nicolas Leupin as Chief Medical Officer


Novocure (NASDAQ: NVCR) today announced the appointment of Nicolas Leupin, M.D., Ph.D., MBA to the role of Chief Medical Officer. Dr. Leupin brings a proven track record of leadership and

LivaNova to Announce Fourth-Quarter and Full-Year 2023 Results: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova to Announce Fourth-Quarter and Full-Year 2023 Results


LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its fourth-quarter and full-year 2023 results on Wednesday, February 21, 2024 at 1

Premier, Inc. to Participate in J.P. Morgan Healthcare Conference on January 9, 2024: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier, Inc. to Participate in J.P. Morgan Healthcare Conference on January 9, 2024


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in the J.P. Morgan Healthcare